Mirjana Poljakovic

Uropathogenic Escherichia Coli and Tolerance to Nitric Oxide: The Role of Flavohemoglobin

PURPOSE NO has an important role as part of the innate host response against bacterial infections. Flavohemoglobin, which is encoded by the hmp gene, protects Escherichia coli against nitrosative stress. We compared the NO tolerance of UPEC and nonpathogenic strains, and examined the involvement of flavohemoglobin. MATERIALS AND METHODS The E. coli K12 derivates HB101 and DH5alpha represent nonpathogenic strains, while J96 and IA2 represent UPEC strains. HB101 was used as the host for a pBR322 plasmid carrying the hmp gene. Bacterial tolerance to NO was evaluated by determining cfu. Flavohemoglobin expression was examined using Northern and Western blot analysis. RESULTS In the stationary growth phase, J96 was significantly more tolerant to DETA/NO (Alexis Biochemical, Lausen, Switzerland) (1 mM) compared to HB101 (47% +/- 11% vs 6.4% +/- 3.1% cfu). In the exponential growth phase DETA/NO exposure resulted in 98% +/- 4.6% cfu for J96 and 74% +/- 7.6% cfu for IA2 compared to 15% +/- 5.9% for HB101 and 21% +/- 12% for DH5alpha. HB101 over expressing hmp showed increased tolerance to DETA/NO (0.5 mM) compared to WT HB101 (106% +/- 5.6% vs 67 +/- 6.2%, p <0.01). Northern and Western blot analysis demonstrated increased flavohemoglobin expression after DETA/NO exposure and the strongest expression in HB101 carrying hmp on a multicopy plasmid. CONCLUSIONS UPEC strains were significantly more tolerant to DETA/NO than nonpathogenic strains, which suggests a correlation between virulence and NO tolerance. Flavohemoglobin expression increased after DETA/NO exposure in UPEC and in nonpathogenic strains.

Shaping the Murine Macrophage Phenotype: IL-4 and Cyclic AMP Synergistically Activate the Arginase I Promoter

Arginase I is a marker of murine M2 macrophages and is highly expressed in many inflammatory diseases. The basis for high arginase I expression in macrophages in vivo is incompletely understood but likely reflects integrated responses to combinations of stimuli. Our objective was to elucidate mechanisms involved in modulating arginase I induction by IL-4, the prototypical activator of M2 macrophages. IL-4 and 8-bromo-cAMP individually induce arginase I, but together they rapidly and synergistically induce arginase I mRNA, protein, and promoter activity in murine macrophage cells. Arginase I induction by IL-4 requires binding of the transcription factors STAT6 and C/EBPβ to the IL-4 response element of the arginase I gene. Chromatin immunoprecipitation showed that the synergistic response involves binding of both transcription factors to the IL-4 response element at levels significantly greater than in response to IL-4 alone. The results suggest that C/EBPβ is a limiting factor for the level of STAT6 bound to the IL-4 response element. The enhanced binding in the synergistic response was not due to increased expression of either STAT6 or C/EBPβ but was correlated primarily with increased nuclear abundance of C/EBPβ. Our findings also suggest that induction of arginase I expression is stochastic; that is, differences in induction reflect differences in probability of transcriptional activation and not simply differences in rate of transcription. Results of the present study also may be useful for understanding mechanisms underlying regulated expression of other genes in macrophages and other myeloid-derived cells in health and disease.

Cell- and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation.

Arginase induction was reported in several inflammatory lung diseases, suggesting that this may be a common feature underlying the pathophysiology of such diseases. As little is known regarding arginase expression in silicosis, the induction and cellular localization of arginase were elucidated in lungs of Sprague-Dawley rats 24 h following exposure to varying doses of silica by intratracheal instillation. Arginase expression was evaluated by activity assay, quantification of arginase I and arginase II mRNA levels using real-time polymerase chain reaction (PCR), and immunohistochemistry. Analyses of cells and fluid obtained by bronchoalveolar lavage (BAL) showed that markers of pulmonary inflammation, tissue damage, activation of alveolar macrophages (AM) and NO production were significantly increased by all silica doses. Arginase activity was increased also in AMs isolated from BAL fluid of silica-treated rats. Silica produced two- and three-fold increases in arginase activity of whole lung at doses of 1 and 5 mg/100 g body weight, respectively. Levels of arginase I mRNA, but not of arginase II mRNA, were similarly elevated. In control lungs, arginase I immunoreactivity was observed only in AMs sparsely dispersed throughout the lung; no inducible nitric oxide synthase (iNOS) immunoreactivity was detected. In silica-treated lungs, arginase I and iNOS were co-expressed in most AMs that were abundantly clustered at inflammatory foci. The rapid induction of arginase I expression in inflammatory lung cells, similar to induction of arginase in other inflammatory lung diseases, implicates elevated arginase activity as a factor in the development of lung damage following exposure to silica.